EP4175632A4 - FORMULATION COMPRISING VILDAGLIPTIN AND AT LEAST ONE PHARMACEUTICALLY ACCEPTABLE EXCIPIENT - Google Patents

FORMULATION COMPRISING VILDAGLIPTIN AND AT LEAST ONE PHARMACEUTICALLY ACCEPTABLE EXCIPIENT Download PDF

Info

Publication number: EP4175632A4
Authority: EP; European Patent Office
Prior art keywords: vildagliptin; formulation; pharmaceutically acceptable; acceptable excipient; excipient
Prior art date: 2020-07-06
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

EP21837553.3A

Other languages

German (de)

French (fr)

Other versions

EP4175632A1 (en

Inventor

Vildan TOMBAYOGLU

Arzu PALANTOKEN

Fatih Sunel

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sanovel Ilac Sanayi ve Ticaret AS

Original Assignee

Sanovel Ilac Sanayi ve Ticaret AS

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2020-07-06

Filing date

2021-05-07

Publication date

2024-08-07

2021-05-07 Application filed by Sanovel Ilac Sanayi ve Ticaret AS filed Critical Sanovel Ilac Sanayi ve Ticaret AS

2023-05-10 Publication of EP4175632A1 publication Critical patent/EP4175632A1/en

2024-08-07 Publication of EP4175632A4 publication Critical patent/EP4175632A4/en

Status Pending legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Inorganic Chemistry (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

EP21837553.3A 2020-07-06 2021-05-07 FORMULATION COMPRISING VILDAGLIPTIN AND AT LEAST ONE PHARMACEUTICALLY ACCEPTABLE EXCIPIENT Pending EP4175632A4 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
TR2020/10700A TR202010700A2 (en)	2020-07-06	2020-07-06	A FORMULATION CONTAINING VILDAGLIPTIN AND AT LEAST ONE PHARMACEUTICALLY ACCEPTABLE EXCLUSIVE
PCT/TR2021/050444 WO2022010436A1 (en)	2020-07-06	2021-05-07	A formulation comprising vildagliptin and at least one pharmaceutically acceptable excipient

Publications (2)

Publication Number	Publication Date
EP4175632A1 EP4175632A1 (en)	2023-05-10
EP4175632A4 true EP4175632A4 (en)	2024-08-07

Family

ID=79553558

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP21837553.3A Pending EP4175632A4 (en)	2020-07-06	2021-05-07	FORMULATION COMPRISING VILDAGLIPTIN AND AT LEAST ONE PHARMACEUTICALLY ACCEPTABLE EXCIPIENT

Country Status (3)

Country	Link
EP (1)	EP4175632A4 (en)
TR (1)	TR202010700A2 (en)
WO (1)	WO2022010436A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20060210627A1 (en) *	2005-01-18	2006-09-21	Sabine Pfeffer	Direct compression formulation and process
CN101106977A (en) *	2005-01-18	2008-01-16	诺瓦提斯公司	Formulation and method of direct compression tablet
US20080193529A1 (en) *	2005-06-10	2008-08-14	James Kowalski	Direct Compression Formulation and Process
WO2019219920A1 (en) *	2018-05-18	2019-11-21	Galenicum Health S.L.U	Stable pharmaceutical compositions of dpp-iv inhibitors in combination with metformin in the form of immediate release tablets

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2915528A1 (en) *	2014-03-06	2015-09-09	Sanovel Ilac Sanayi ve Ticaret A.S.	Vildagliptin formulation process under inert gas atmosphere

2020
- 2020-07-06 TR TR2020/10700A patent/TR202010700A2/en unknown
2021
- 2021-05-07 WO PCT/TR2021/050444 patent/WO2022010436A1/en not_active Ceased
- 2021-05-07 EP EP21837553.3A patent/EP4175632A4/en active Pending

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20060210627A1 (en) *	2005-01-18	2006-09-21	Sabine Pfeffer	Direct compression formulation and process
CN101106977A (en) *	2005-01-18	2008-01-16	诺瓦提斯公司	Formulation and method of direct compression tablet
US20080193529A1 (en) *	2005-06-10	2008-08-14	James Kowalski	Direct Compression Formulation and Process
WO2019219920A1 (en) *	2018-05-18	2019-11-21	Galenicum Health S.L.U	Stable pharmaceutical compositions of dpp-iv inhibitors in combination with metformin in the form of immediate release tablets

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2022010436A1 *

Also Published As

Publication number	Publication date
WO2022010436A1 (en)	2022-01-13
EP4175632A1 (en)	2023-05-10
TR202010700A2 (en)	2022-01-21

Similar Documents

Publication	Publication Date	Title
IL275704A (en)	2020-08-31	Oral pharmaceutical formulation comprising cannabinoids and poloxamer
EP4149470A4 (en)	2024-04-24	PHARMACEUTICAL FORMULATIONS AND USES THEREOF
EP4045480A4 (en)	2023-11-22	PHARMACEUTICAL FORMULATIONS
BR112015023391A8 (en)	2018-01-30	anti-egfr antibody-drug conjugate formulations
AR103246A1 (en)	2017-04-26	DERIVATIVES OF FGF21 AND ITS USES
PH12019501076A1 (en)	2019-08-19	Pharmaceutical formulations
EP4215208A4 (en)	2024-11-20	Pharmaceutical combination and use thereof
ES2850277R1 (en)	2023-07-07	Pharmaceutical administration compositions and uses thereof
IL311331A (en)	2024-05-01	Pharmaceutical preparation and its use
PH12017502322B1 (en)	2023-08-30	Therapeutic agent for fibrosis
IL288645A (en)	2022-02-01	Saponin conjugate and vaccine or pharmaceutical composition comprising the same
IL289943A (en)	2022-03-01	Medicinal and/or pharmaceutical compositions for intravesical instillation, preparation and use thereof
IL299671A (en)	2023-03-01	Viscosity reducing excipients and combinations thereof for highly concentrated protein formulations
EP4175632A4 (en)	2024-08-07	FORMULATION COMPRISING VILDAGLIPTIN AND AT LEAST ONE PHARMACEUTICALLY ACCEPTABLE EXCIPIENT
HK1245131A1 (en)	2018-08-24	Combination comprising palmitoylethanolamide (pea) and lycopene for use in the treatment of inflammatory diseases
EP3921322C0 (en)	2025-09-03	PHOSPHOR-IMIDAZOQUINOLINE-AMINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC METHODS THEREOF
GB202005282D0 (en)	2020-05-27	Pharmaceutical Formulations
IL312874A (en)	2024-07-01	Pharmaceutical preparation and its use
EP4101466A4 (en)	2023-07-12	HYALURONIC ACID DERIVATIVE COMPOSITION, PHARMACEUTICAL COMPOSITION AND HYALURONIC ACID DERIVATIVE-ACTIVE CONJUGATE COMPOSITION
EP4042999C0 (en)	2026-03-04	Drug intake device for solid oral formulation as well as oral administration and dispensing device thereby
EP3965759A4 (en)	2023-01-18	TABLET FORMULATION COMPRISING LERCANIDIPINE AND ENALAPRIL
IL314206A (en)	2024-09-01	Pharmaceutical formulation
CR20220587A (en)	2023-01-09	PHARMACEUTICAL FORMULATIONS
EP4342492A4 (en)	2025-01-15	Pharmaceutical combination and use thereof
CL2022001426A1 (en)	2023-03-24	Pediatric immediate-release formulation of the potassium channel opener ezogabine

Legal Events

Date	Code	Title	Description
2022-01-14	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE
2023-04-07	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2023-04-07	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE
2023-05-10	17P	Request for examination filed	Effective date: 20230105
2023-05-10	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2023-08-16	P01	Opt-out of the competence of the unified patent court (upc) registered	Effective date: 20230708
2023-10-11	DAV	Request for validation of the european patent (deleted)
2023-10-11	DAX	Request for extension of the european patent (deleted)
2024-08-07	A4	Supplementary search report drawn up and despatched	Effective date: 20240705
2024-08-07	RIC1	Information provided on ipc code assigned before grant	Ipc: A61K 9/20 20060101ALI20240701BHEP Ipc: A61K 31/40 20060101AFI20240701BHEP
2025-01-01	RAP3	Party data changed (applicant data changed or rights of an application transferred)	Owner name: SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
2025-01-08	RAP3	Party data changed (applicant data changed or rights of an application transferred)	Owner name: SANOVEL ILAC SANAYI VE TICARET A.S.